Active neovascular AMD in 1 eye increases risk of fellow eye conversion
- Posted on: Sep 26 2019
- Leave a response
This secondary analysis of data from 2 clinical trials explores whether the type of anti-VEGF agent and baseline characteristics influence fellow eye conversion to neovascular AMD.
Source: AAO
Posted in: Uncategorized